SG11201908489XA - De novo synthesized combinatorial nucleic acid libraries - Google Patents

De novo synthesized combinatorial nucleic acid libraries

Info

Publication number
SG11201908489XA
SG11201908489XA SG11201908489XA SG11201908489XA SG 11201908489X A SG11201908489X A SG 11201908489XA SG 11201908489X A SG11201908489X A SG 11201908489XA SG 11201908489X A SG11201908489X A SG 11201908489XA
Authority
SG
Singapore
Prior art keywords
nucleic acid
international
blvd
suite
california
Prior art date
Application number
Other languages
English (en)
Inventor
Anthony Cox
Siyuan Chen
Charles Ledogar
Dominique Toppani
Original Assignee
Twist Bioscience Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Twist Bioscience Corp filed Critical Twist Bioscience Corp
Publication of SG11201908489XA publication Critical patent/SG11201908489XA/en

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B35/00—ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
    • G16B35/10—Design of libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • C40B40/08—Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
    • C40B50/06—Biochemical methods, e.g. using enzymes or whole viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Library & Information Science (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
SG11201908489X 2017-03-15 2018-03-14 De novo synthesized combinatorial nucleic acid libraries SG11201908489XA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762471723P 2017-03-15 2017-03-15
US201762578326P 2017-10-27 2017-10-27
PCT/US2018/022487 WO2018170164A1 (en) 2017-03-15 2018-03-14 De novo synthesized combinatorial nucleic acid libraries

Publications (1)

Publication Number Publication Date
SG11201908489XA true SG11201908489XA (en) 2019-10-30

Family

ID=63523968

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201908489X SG11201908489XA (en) 2017-03-15 2018-03-14 De novo synthesized combinatorial nucleic acid libraries

Country Status (11)

Country Link
US (1) US20180282721A1 (cg-RX-API-DMAC7.html)
EP (1) EP3596258A4 (cg-RX-API-DMAC7.html)
JP (2) JP7335165B2 (cg-RX-API-DMAC7.html)
KR (2) KR20230163591A (cg-RX-API-DMAC7.html)
CN (2) CN110914486B (cg-RX-API-DMAC7.html)
AU (2) AU2018234624B2 (cg-RX-API-DMAC7.html)
CA (1) CA3056386A1 (cg-RX-API-DMAC7.html)
GB (1) GB2575576A (cg-RX-API-DMAC7.html)
IL (1) IL269288A (cg-RX-API-DMAC7.html)
SG (1) SG11201908489XA (cg-RX-API-DMAC7.html)
WO (1) WO2018170164A1 (cg-RX-API-DMAC7.html)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102160389B1 (ko) 2013-08-05 2020-09-28 트위스트 바이오사이언스 코포레이션 드 노보 합성된 유전자 라이브러리
CA2975852A1 (en) 2015-02-04 2016-08-11 Twist Bioscience Corporation Methods and devices for de novo oligonucleic acid assembly
WO2016172377A1 (en) 2015-04-21 2016-10-27 Twist Bioscience Corporation Devices and methods for oligonucleic acid library synthesis
KR20180050411A (ko) 2015-09-18 2018-05-14 트위스트 바이오사이언스 코포레이션 올리고핵산 변이체 라이브러리 및 그의 합성
WO2017053450A1 (en) 2015-09-22 2017-03-30 Twist Bioscience Corporation Flexible substrates for nucleic acid synthesis
EP3384077A4 (en) 2015-12-01 2019-05-08 Twist Bioscience Corporation FUNCTIONALIZED SURFACES AND MANUFACTURE THEREOF
WO2018038772A1 (en) 2016-08-22 2018-03-01 Twist Bioscience Corporation De novo synthesized nucleic acid libraries
EP4664304A3 (en) 2016-09-21 2026-01-21 Atlas Data Storage, Inc. Nucleic acid based data storage
GB2573069A (en) 2016-12-16 2019-10-23 Twist Bioscience Corp Variant libraries of the immunological synapse and synthesis thereof
WO2018156792A1 (en) 2017-02-22 2018-08-30 Twist Bioscience Corporation Nucleic acid based data storage
AU2018234624B2 (en) * 2017-03-15 2023-11-16 Twist Bioscience Corporation De novo synthesized combinatorial nucleic acid libraries
CA3056388A1 (en) 2017-03-15 2018-09-20 Twist Bioscience Corporation Variant libraries of the immunological synapse and synthesis thereof
WO2018231864A1 (en) 2017-06-12 2018-12-20 Twist Bioscience Corporation Methods for seamless nucleic acid assembly
IL271205B2 (en) 2017-06-12 2025-02-01 Twist Bioscience Corp Methods for assembling continuous nucleic acids
CN111566125A (zh) 2017-09-11 2020-08-21 特韦斯特生物科学公司 Gpcr结合蛋白及其合成
CN111565834B (zh) 2017-10-20 2022-08-26 特韦斯特生物科学公司 用于多核苷酸合成的加热的纳米孔
IL312616B2 (en) 2018-01-04 2025-08-01 Twist Bioscience Corp Dna-based digital information storage
EP3814497A4 (en) 2018-05-18 2022-03-02 Twist Bioscience Corporation POLYNUCLEOTIDES, REAGENTS AND METHODS FOR NUCLEIC ACID HYBRIDIZATION
EP3902816A4 (en) 2018-12-26 2022-09-14 Twist Bioscience Corporation HIGH-PRECISION DE NOVO POLYNUCLEOTIDE SYNTHESIS
KR20210144698A (ko) 2019-02-26 2021-11-30 트위스트 바이오사이언스 코포레이션 항체 최적화를 위한 변이 핵산 라이브러리
CA3131689A1 (en) * 2019-02-26 2020-09-03 Twist Bioscience Corporation Variant nucleic acid libraries for glp1 receptor
EP3987019A4 (en) 2019-06-21 2023-04-19 Twist Bioscience Corporation Barcode-based nucleic acid sequence assembly
CN115023440B (zh) 2019-09-23 2025-09-12 特韦斯特生物科学公司 结合CD3ε的抗体
US12091777B2 (en) 2019-09-23 2024-09-17 Twist Bioscience Corporation Variant nucleic acid libraries for CRTH2
AU2020400030B2 (en) 2019-12-09 2026-05-21 Twist Bioscience Corporation Variant nucleic acid libraries for adenosine receptors
BR112022021780A2 (pt) 2020-04-27 2023-03-07 Twist Bioscience Corp Bibliotecas de ácido nucléico variantes para coronavírus
CA3190667A1 (en) 2020-08-26 2022-03-03 Aaron Sato Methods and compositions relating to glp1r variants
US12534494B2 (en) 2020-08-28 2026-01-27 Twist Bioscience Corporation Devices and methods for synthesis
EP4229210A4 (en) 2020-10-19 2025-01-08 Twist Bioscience Corporation METHOD FOR THE SYNTHESIS OF OLIGONUCLEOTIDES USING BOUND NUCLEOTIDES
WO2022159620A1 (en) 2021-01-21 2022-07-28 Twist Bioscience Corporation Methods and compositions relating to adenosine receptors
US12258406B2 (en) 2021-03-24 2025-03-25 Twist Bioscience Corporation Antibodies that bind CD3 Epsilon
WO2022235584A1 (en) 2021-05-03 2022-11-10 Twist Bioscience Corporation Variant nucleic acid libraries for glycans
WO2022271884A2 (en) 2021-06-22 2022-12-29 Twist Bioscience Corporation Methods and compositions relating to covid antibody epitopes
WO2023023285A2 (en) 2021-08-19 2023-02-23 Twist Bioscience Corporation Methods and compositions relating to covalently closed nucleic acids
US12697597B2 (en) 2021-11-01 2026-08-04 Twist Bioscience Corporation Methods for polynucleotide synthesis
EP4433085A2 (en) 2021-11-18 2024-09-25 Twist Bioscience Corporation Dickkopf-1 variant antibodies and methods of use
US12325739B2 (en) 2022-01-03 2025-06-10 Twist Bioscience Corporation Bispecific SARS-CoV-2 antibodies and methods of use
WO2023154533A2 (en) * 2022-02-14 2023-08-17 Twist Bioscience Corporation Combinatorial dna assembly for multispecific antibodies
EP4490318A4 (en) 2022-03-07 2026-06-10 Twist Bioscience Corp METHYLATION-MEDIATED ADAPTER ELIMINATION ON NUCLEIC ACID SEQUENCES
US12632706B2 (en) * 2022-04-07 2026-05-19 Winbond Electronics Corp. Light source optimization apparatus and light source optimization method
CN114694757B (zh) * 2022-04-20 2025-04-18 中南民族大学 Rna序列编码潜力预测方法及系统
WO2025217152A1 (en) * 2024-04-09 2025-10-16 Octant, Inc. Methods and systems for identifying functional sites
WO2025250626A2 (en) * 2024-05-28 2025-12-04 Immorna Biotherapeutics Inc. Mrna composition and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681702A (en) * 1994-08-30 1997-10-28 Chiron Corporation Reduction of nonspecific hybridization by using novel base-pairing schemes
WO2003014325A2 (en) * 2001-08-10 2003-02-20 Xencor Protein design automation for protein libraries
WO2008045380A2 (en) * 2006-10-04 2008-04-17 Codon Devices, Inc. Nucleic acid libraries and their design and assembly
JP5675109B2 (ja) * 2007-02-20 2015-02-25 アナプティスバイオ インコーポレイティッド ライブラリーの生成方法及びその使用
US8401798B2 (en) * 2008-06-06 2013-03-19 Dna Twopointo, Inc. Systems and methods for constructing frequency lookup tables for expression systems
US20110082055A1 (en) * 2009-09-18 2011-04-07 Codexis, Inc. Reduced codon mutagenesis
EP2890836B1 (en) * 2012-08-31 2019-07-17 The Scripps Research Institute Methods related to modulators of eukaryotic cells
KR102160389B1 (ko) * 2013-08-05 2020-09-28 트위스트 바이오사이언스 코포레이션 드 노보 합성된 유전자 라이브러리
KR20180050411A (ko) * 2015-09-18 2018-05-14 트위스트 바이오사이언스 코포레이션 올리고핵산 변이체 라이브러리 및 그의 합성
AU2018234624B2 (en) * 2017-03-15 2023-11-16 Twist Bioscience Corporation De novo synthesized combinatorial nucleic acid libraries

Also Published As

Publication number Publication date
CN110914486B (zh) 2024-01-30
IL269288A (en) 2019-11-28
GB2575576A (en) 2020-01-15
US20180282721A1 (en) 2018-10-04
KR102607157B1 (ko) 2023-11-27
JP7696937B2 (ja) 2025-06-23
JP7335165B2 (ja) 2023-08-29
GB201914881D0 (en) 2019-11-27
AU2018234624B2 (en) 2023-11-16
WO2018170164A1 (en) 2018-09-20
AU2018234624A1 (en) 2019-10-17
CA3056386A1 (en) 2018-09-20
EP3596258A1 (en) 2020-01-22
JP2020511135A (ja) 2020-04-16
AU2024201012A1 (en) 2024-06-06
CN110914486A (zh) 2020-03-24
JP2023087685A (ja) 2023-06-23
EP3596258A4 (en) 2020-12-30
CN117888207A (zh) 2024-04-16
KR20190129081A (ko) 2019-11-19
KR20230163591A (ko) 2023-11-30

Similar Documents

Publication Publication Date Title
SG11201906200WA (en) Nucleic acid-polypeptide compositions and methods of inducing exon skipping
SG11201901563UA (en) De novo synthesized nucleic acid libraries
SG11201906717SA (en) Methods and systems for associating physical and genetic properties of biological particles
SG11201910070PA (en) Universal short adapters for indexing of polynucleotide samples
SG11201907056XA (en) Compositions and methods for the treatment of hemoglobinopathies
SG11201908719QA (en) Biomarkers and car t cell therapies with enhanced efficacy
SG11201811232XA (en) Treatment of amd using aav2 variant with aflibercept
SG11201907531XA (en) Constraining motion vector information derived by decoder-side motion vector derivation
SG11201909011PA (en) Niraparib compositions
SG11201811025VA (en) Systems and methods for automated annotation and screening of biological sequences
SG11201906297QA (en) Nucleic acids encoding crispr-associated proteins and uses thereof
SG11201803958WA (en) Nucleic acids encoding repetitive amino acid sequences rich in proline and alanine residues that have low repetitive nucleotide sequences
SG11202000274RA (en) Oligonucleotide compositions and methods thereof
SG11201810179RA (en) Novel crispr enzymes and systems
SG11201908393YA (en) Modulators of pcsk9 expression
SG11201907713WA (en) Nucleic acid based data storage
SG11201908658TA (en) Nucleobase editors comprising nucleic acid programmable dna binding proteins
SG11201810019RA (en) Methods of human leukocyte antigen typing
SG11201908391XA (en) Methods for modulating an immune response
SG11201909205YA (en) Immunoconjugates of an anti-pd-1 antibody with a mutant il-2 or with il-15
SG11201807366WA (en) System and method for generating custom shoe insole
SG11201804771WA (en) Systems and methods for providing financial data to financial instruments in a distributed ledger system
SG11201808261RA (en) Genetic variant-phenotype analysis system and methods of use
SG11201806117TA (en) Computer security based on artificial intelligence
SG11201903882VA (en) Il-2 variants for the treatment of autoimmune diseases